Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer
Open Access
- 17 May 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 91 (6), 699-704
- https://doi.org/10.1002/bjs.4603
Abstract
Background: Breast cancer has been considered a more indolent disease in the elderly, who are less tolerant of aggressive therapy. This trial tested the hypothesis that tamoxifen without surgery would provide adequate control of breast cancer for the remainder of life in elderly women, thereby sparing them surgery. Method: Women aged over 70 years with operable, invasive breast cancer were randomized to receive either tamoxifen alone or surgery plus tamoxifen. Time to treatment failure (TTF), indicating initial primary treatment failure, was the primary endpoint. Overall mortality, and death from breast cancer were also compared between the two groups. Results: Between 1984 and 1991, 455 patients were included in the trial. The analysis was based on a median follow-up of 12·7 years. The TTF was significantly shorter in the tamoxifen alone group: hazard ratio (HR) 4·41 (95 per cent confidence interval (c.i.) 3·31 to 5·88). Ninety-three (40·4 per cent) of 230 patients randomized to tamoxifen alone underwent surgery for the management of their disease. Both overall mortality and mortality from breast cancer were significantly increased in the tamoxifen alone group, although the survival curves did not diverge for the first 3 three years: HR 1·29 (95 per cent c.i. 1·04 to 1·59) and 1·68 (95 per cent c.i. 1·15 to 2·47) respectively. Conclusion: Omission of primary surgery in unselected elderly women with operable breast cancer who were fit for the procedure resulted in an increased rate of progression, therapeutic intervention and mortality.Keywords
Funding Information
- Former SE Thames Locally Organised Research Scheme
- Cancer Research UK
- Astra Zeneca plc
- E. B. Hutchinson Trust
This publication has 18 references indexed in Scilit:
- The need for targeted research into breast cancer in the elderlyBritish Journal of Surgery, 2003
- Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trialAnnals of Oncology, 2003
- Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomyEuropean Journal of Cancer, 2003
- Long-term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancerThe Breast, 1998
- Investigation of primary tamoxifen therapy for elderly patients with operable breast cancerThe Breast, 1997
- Factors Associated With Surgical and Radiation Therapy for Early Stage Breast Cancer in Older WomenJNCI Journal of the National Cancer Institute, 1996
- Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen aloneBritish Journal of Surgery, 1991
- Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen onlyBritish Journal of Surgery, 1991
- Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survivalCancer, 1989
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977